Key result
Chronic noradrenaline elevation blunts pressor response to exogenous noradrenaline compared to controls.
Why the study?
The mechanisms underlying the absence of arterial hypertension despite chronic elevated plasma noradrenaline levels were unclear, providing an opportunity to investigate alpha-adrenoceptor regulation in vivo.
Case Report (n=1)
High endogenous NA without pressor response to infusion suggests receptor adaptation; leaves open in vivo adrenoceptor regulation questions.
A 44 year old-healthy female presented chronic and stable high levels of plasma noradrenaline (NA) without any major change in adrenaline. The diagnosis of phaeochromocytoma was discarded. These increased levels of NA offered an unique opportunity to investigate under in vivo conditions a putative regulation of alpha-adrenoceptors by this endogenous catecholamine. Infusion rates of exogenous NA up to 0.74 micrograms/kg per min were unable to induce any change in blood pressure (or heart rate) in the subject, In contrast, in normotensive controls, an increase in blood pressure (+ 15 mm Hg) was observed with 0.39 micrograms/kg per min. The magnitude of yohimbine-induced increase in plasma NA was similar in the subject and in the controls. Platelet alpha 2-adrenoceptors evaluated by specific [3H]-yohimbine binding showed a significantly lower level in the subject when compared to controls. The results show that a sustained increase in plasma NA is able to induce down-regulation of alpha-adrenoceptors. This down-regulation can explain the lack of arterial hypertension despite the increased sympathetic tone.
No takes yet. Share an insight, caveat, or question.
Sénard et al. (1991) conducted a case report in Chronic plasma noradrenaline elevation (n=1). Chronic plasma noradrenaline elevation and exogenous noradrenaline infusion vs. Normotensive controls was evaluated on Change in blood pressure during exogenous noradrenaline infusion. A patient with chronic plasma noradrenaline elevation showed no blood pressure increase during exogenous noradrenaline infusion, compared to a 15 mm Hg increase in normotensive controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: